The growing prevalence of infectious diseases, increasing antimicrobial resistance (AMR), and the rising demand for rapid diagnostic solutions are the key drivers of growth in the global clinical ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...

Validating sample collection by deep suction has potential to accelerate and expand adoption of CyPath® LungSAN ANTONIO--(BUSINESS WIRE)--$BIAF #BAMC--bioAffinity Technologies, Inc. (Nasdaq: BIAF; ...

What is the Market Size of Precision Medicine Research and Development Platform? The global market for Precision Medicine ...

SIRPα immunotherapy include targeting overexpressed CD47 in cancers to boost macrophage activity, using dual function molecules to enhance efficacy, and innovative drug designs reducing red blood cell ...

In a collaboration between several labs at UNC Lineberger, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

The main market opportunities in the CLDN18.2-targeted immunotherapy space include next-gen monoclonal antibodies with enhanced efficacy, innovative antibody-drug conjugates (ADCs), advanced CAR-T and ...

Cardiac surgery continues to evolve through innovation, refined technique, and improved perioperative care. Yet many of the ...

Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting biomarker discovery.

GPC3-targeted immunotherapies present significant market opportunities for hepatocellular carcinoma treatment due to GPC3's selective expression in HCC and absence in normal liver tissue. Innovative ...